IL308407A - Novel protein and nucleic acid sequences for covid-19 vaccines - Google Patents

Novel protein and nucleic acid sequences for covid-19 vaccines

Info

Publication number
IL308407A
IL308407A IL308407A IL30840723A IL308407A IL 308407 A IL308407 A IL 308407A IL 308407 A IL308407 A IL 308407A IL 30840723 A IL30840723 A IL 30840723A IL 308407 A IL308407 A IL 308407A
Authority
IL
Israel
Prior art keywords
covid
vaccines
nucleic acid
acid sequences
novel protein
Prior art date
Application number
IL308407A
Other languages
English (en)
Hebrew (he)
Original Assignee
Dompe Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farm Spa filed Critical Dompe Farm Spa
Publication of IL308407A publication Critical patent/IL308407A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL308407A 2021-05-14 2022-05-16 Novel protein and nucleic acid sequences for covid-19 vaccines IL308407A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21173941.2A EP4088738A1 (en) 2021-05-14 2021-05-14 Novel protein and nucleic acid sequences for covid-19 vaccines
PCT/EP2022/063214 WO2022238585A1 (en) 2021-05-14 2022-05-16 Novel protein and nucleic acid sequences for covid-19 vaccines

Publications (1)

Publication Number Publication Date
IL308407A true IL308407A (en) 2024-01-01

Family

ID=75936784

Family Applications (1)

Application Number Title Priority Date Filing Date
IL308407A IL308407A (en) 2021-05-14 2022-05-16 Novel protein and nucleic acid sequences for covid-19 vaccines

Country Status (10)

Country Link
US (1) US20250282831A1 (enExample)
EP (2) EP4088738A1 (enExample)
JP (1) JP2024517345A (enExample)
CN (1) CN117915945A (enExample)
AU (1) AU2022272659A1 (enExample)
BR (1) BR112023023794A2 (enExample)
CA (1) CA3219586A1 (enExample)
IL (1) IL308407A (enExample)
WO (1) WO2022238585A1 (enExample)
ZA (1) ZA202311432B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024245344A1 (zh) * 2023-05-30 2024-12-05 石药集团巨石生物制药有限公司 预防新型冠状病毒奥密克戎突变株的mRNA疫苗

Also Published As

Publication number Publication date
EP4088738A1 (en) 2022-11-16
CN117915945A (zh) 2024-04-19
CA3219586A1 (en) 2022-11-17
AU2022272659A1 (en) 2023-11-23
JP2024517345A (ja) 2024-04-19
WO2022238585A1 (en) 2022-11-17
AU2022272659A9 (en) 2023-11-30
ZA202311432B (en) 2025-04-30
US20250282831A1 (en) 2025-09-11
BR112023023794A2 (pt) 2024-03-12
EP4337250A1 (en) 2024-03-20

Similar Documents

Publication Publication Date Title
IL286335A (en) Methods and compositions for editing nucleotide sequences
IL289052A (en) Transdermal penetrant formulations containing cannabidiol
PL3746564T3 (pl) Sposób amplifikacji kwasów nukleinowych
IL288360A (en) Anti-vegf protein compositions and methods for producing the same
IL259788A (en) Adapter nucleic acid sequences, compositions comprising same and methods for duplex sequencing using same
EP4376883A4 (en) RNA VACCINES
DK3821011T3 (da) Transposom-aktiveret dna/rna-sekventering (ted rna-seq)
EP4227319C0 (en) NEW RSV RNA MOLECULES AND COMPOSITIONS FOR VACCINATION
EP3781670A4 (en) FUSION PROTEINS AND RIBONUCLEIC ACIDS FOR TRACKING AND MANIPULATION OF CELLULAR RNA
DK3957744T5 (da) Reagenser og fremgangsmåder til molekylær stregkodning af enkeltcellenukleinsyrer
DK3115457T3 (da) Fremgangsmåde til modificering af genomsekvens til specifikt at konvertere nukleinsyrebaser af målrettet dna-sekvens og molekylært kompleks til anvendelse i samme
EP3867372C0 (en) METHODS FOR TARGETED INSERTION OF DNA INTO GENES
EP3997205A4 (en) Rna sequencing methods
EP3616204C0 (en) METHOD FOR ALIGNING TARGETED NUCLEIC ACID SEQUENCING DATA
ITUA20162640A1 (it) Metodo e kit per la generazione di librerie di dna per sequenziamento massivo parallelo
EP4166158A4 (en) NUCLEIC ACID LIPID PARTICLE VACCINE
DK3589748T3 (da) Nukleinsyremodifikation og identifikationsfremgangsmåde
EP3344643A4 (en) PROCESS FOR THE JOINT INSULATION OF NUCLEIC ACIDS AND PROTEINS
EP4081648A4 (en) Method and kit for template-independent nucleic acid synthesis
DK3833786T5 (da) Rekombinant nucleinsyrekonstrukt
EP4143209A4 (en) Modified immunogenic proteins
EP3908677C0 (en) METHOD FOR DETECTING A NUCLEIC ACID SEQUENCE
EP4240412A4 (en) VACCINE AGAINST GENE-REARRANGED LYSSAVIRUSES
EP3914734C0 (en) COMPOSITIONS AND METHOD FOR SYNTHESIS OF NUCLEIC ACIDS
EP4382110A4 (en) HAIRPIN NUCLEIC ACID COMPOSITION